Ignite Creation Date:
2024-05-06 @ 12:27 PM
Last Modification Date:
2024-10-26 @ 12:59 PM
Study NCT ID:
NCT03767348
Status:
RECRUITING
Last Update Posted:
2023-08-02
First Post:
2018-12-05
Brief Title:
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab
Sponsor:
Replimune Inc
Organization:
Replimune Inc
Organization Data
Organization:
Replimune Inc
Class:
INDUSTRY
Study ID:
RPL-001-16
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Replimune Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None